Avian Influenza A H7N9 Hemagglutinin antibody is affinity chromatography purified via peptide column.
Immunogen
Avian Influenza A H7N9 Hemagglutinin antibody was raised against a synthetic peptide corresponding to 11 amino acids near the center of the H7N9 [Influenza A virus (A/Shanghai/02/2013(H7N9))] hemagglutinin protein. The immunogen is located within amino acids 260 - 310 of Avian Influenza A H7N9 Hemagglutinin.
HA
Reaktivität: Influenza A Virus
ELISA, WB
Wirt: Maus
Monoclonal
HA22-C
unconjugated
Applikationshinweise
Avian Influenza A H7N9 Hemagglutinin antibody can be used for detection of Avian Influenza A H7N9 Hemagglutinin by ELISA at 1 μ,g/mL.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1 mg/mL
Buffer
Avian Influenza A H7N9 Hemagglutinin Antibody is supplied in PBS containing 0.02 % sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C,4 °C
Informationen zur Lagerung
Avian Influenza A H7N9 Hemagglutinin antibody can be stored at 4°C for three months and -20°C, stable for up to one year.
Target
Hemagglutinin (HA)
Andere Bezeichnung
Avian Influenza A H7N9 Hemagglutinin (HA Produkte)
Synonyme
hemagglutinin antikoerper, Hemagglutinin antikoerper, HA antikoerper, HA antikoerper, ha antikoerper
Substanzklasse
Influenza Protein
Hintergrund
Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA (1). Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals, however it is in birds that all subtypes can be found (2). These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. H7N9 bird flu is the newest atypical influenza virus infection that has just been reported since early 2013. The emergence of this new strain occurred in China and has become the present focus for possible worldwide pandemic (3).